NIH: Company shaped sepsis guidelines

10/18/2006 | NYTimes.com · Wall Street Journal, The

A group of NIH physicians says Eli Lilly manipulated medical guidelines for treating sepsis, a blood infection, to promote use of its drug Xigris. Lilly said it is looking into the accusations but said it did not believe it had a role in the content of the guidelines beyond paying for the effort to draft guidelines.

View Full Article in:

NYTimes.com · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Chief Executive Officer
UCare Minnesota
Minneapolis, MN
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC